Tanshinone IIA Suppresses Glioma Cell Proliferation, Migration and Invasion Both in vitro and in vivo Partially Through miR-16-5p/Talin-1 (TLN1) Axis

References

• Javed S, Tariq A, Ahmed T, et al. Tanshinones and mental diseases: from chemistry to medicine. Rev Neurosci. 2016;27(8):777–791. doi:10.1515/revneuro-2016-001227487490
   PubMed Web of Science ®Google Scholar
• Xu S, Liu P. Tanshinone II-A: new perspectives for old remedies. Expert Opin Ther Pat. 2013;23(2):149–153. doi:10.1517/13543776.2013.74399523231009
   PubMed Web of Science ®Google Scholar
• Tian XH, Wu JH. Tanshinone derivatives: a patent review (January 2006–September 2012). Expert Opin Ther Pat. 2013;23(1):19–29. doi:10.1517/13543776.2013.73649423094864
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang P, Ye M, Kim SH, Jiang C, Lu J. Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci. 2012;13(10):13621–13666. doi:10.3390/ijms13101362123202971
   PubMed Web of Science ®Google Scholar
• Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet. 2018;392(10145):432–446. doi:10.1016/S0140-6736(18)30990-530060998
   PubMed Web of Science ®Google Scholar
• Darefsky AS, King JT Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries. Cancer. 2012;118(8):2163–2172. doi:10.1002/cncr.2649421882183
   PubMed Web of Science ®Google Scholar
• Weller M, van den Bent M, Tonn JC, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol. 2017;18(6):e315–e329. doi:10.1016/S1470-2045(17)30194-828483413
   PubMed Web of Science ®Google Scholar
• Chen MH, Jenh YJ, Wu SK, Chen YS, Hanagata N, Lin FH. Non-invasive photodynamic therapy in brain cancer by use of Tb(3+)-Doped LaF3 nanoparticles in combination with photosensitizer through X-ray irradiation: a Proof-of-Concept Study. Nanoscale Res Lett. 2017;12(1):62. doi:10.1186/s11671-017-1840-328110445
   PubMedGoogle Scholar
• Tang C, Xue H, Bai C, Fu R, Wu A. The effects of tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine. 2010;17(14):1145–1149. doi:10.1016/j.phymed.2010.03.01720570121
   PubMed Web of Science ®Google Scholar
• Lam BY, Lo AC, Sun X, Luo HW, Chung SK, Sucher NJ. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine. 2003;10(4):286–291. doi:10.1078/09447110332200477612809358
   PubMed Web of Science ®Google Scholar
• Ahir BK, Ozer H, Engelhard HH, Lakka SS. MicroRNAs in glioblastoma pathogenesis and therapy: a comprehensive review. Crit Rev Oncol Hematol. 2017;120:22–33. doi:10.1016/j.critrevonc.2017.10.00329198335
   PubMed Web of Science ®Google Scholar
• Guo Y, Hong W, Wang X, et al. MicroRNAs in microglia: how do MicroRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and glioma? Front Mol Neurosci. 2019;12:125. doi:10.3389/fnmol.2019.0012531133802
   PubMed Web of Science ®Google Scholar
• Xu X, Jiang Q, Ma X, et al. Deep sequencing identifies tissue-specific microRNAs and their target genes involving in the biosynthesis of tanshinones in Salvia miltiorrhiza. PLoS One. 2014;9(11):e111679. doi:10.1371/journal.pone.011167925365305
   PubMed Web of Science ®Google Scholar
• Lin X, Qureshi MZ, Romero MA, et al. Regulation of signaling pathways by tanshinones in different cancers. Cell Mol Biol (Noisy-Le-Grand). 2017;63(9):53–58. doi:10.14715/cmb/2017.63.9.10
   PubMed Web of Science ®Google Scholar
• Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010;17(2):215–220. doi:10.1038/cdd.2009.6919498445
   PubMed Web of Science ®Google Scholar
• Krell A, Wolter M, Stojcheva N, et al. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy. Neuropathol Appl Neurobiol. 2019;45(5):441–458. doi:10.1111/nan.1253230548945
   PubMed Web of Science ®Google Scholar
• Yang TQ, Lu XJ, Wu TF, et al. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-kappaB1/MMP9 signaling pathway. Cancer Sci. 2014;105(3):265–271. doi:10.1111/cas.1235124418124
   PubMed Web of Science ®Google Scholar
• Ye X, Wei W, Zhang Z, et al. Identification of microRNAs associated with glioma diagnosis and prognosis. Oncotarget. 2017;8(16):26394–26403. doi:10.18632/oncotarget.1444528060761
   PubMedGoogle Scholar
• Ivo D’Urso P, Fernando D’Urso O, Damiano Gianfreda C, Mezzolla V, Storelli C, Marsigliante S. miR-15b and miR-21 as circulating biomarkers for diagnosis of glioma. Curr Genomics. 2015;16(5):304–311. doi:10.2174/138920291666615070715561027047250
   PubMed Web of Science ®Google Scholar
• Sen S, Ng WP, Kumar S. Contributions of talin-1 to glioma cell-matrix tensional homeostasis. J R Soc Interface. 2012;9(71):1311–1317. doi:10.1098/rsif.2011.056722158841
   PubMed Web of Science ®Google Scholar
• Di Cesare Mannelli L, Piccolo M, Maione F, et al. Tanshinones from salvia miltiorrhiza bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy. Biomed Pharmacother. 2018;105:1042–1049. doi:10.1016/j.biopha.2018.06.04730021339
   PubMed Web of Science ®Google Scholar
• Wang J, Wang X, Jiang S, et al. Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. J Neurooncol. 2007;82(1):11–21. doi:10.1007/s11060-006-9242-x16955220
   PubMed Web of Science ®Google Scholar
• Dong W, Zhang Y, Chen X, Jia Y. High-dose tanshinone IIA suppresses migration and proliferation while promoting apoptosis of astrocytoma cells via notch-1 pathway. Neurochem Res. 2018;43(9):1855–1861. doi:10.1007/s11064-018-2601-030066161
   PubMed Web of Science ®Google Scholar
• Ding L, Ding L, Wang S, et al. Tanshinone IIA affects autophagy and apoptosis of glioma cells by inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Pharmacology. 2017;99(3–4):188–195. doi:10.1159/00045234027889779
   PubMed Web of Science ®Google Scholar
• Yang L, Guo H, Dong L, Wang L, Liu C, Wang X. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells. Oncol Rep. 2014;32(3):1303–1311. doi:10.3892/or.2014.329324970314
   PubMed Web of Science ®Google Scholar
• Tu J, Xing Y, Guo Y, Tang F, Guo L, Xi T. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. Int Immunopharmacol. 2012;14(4):353–361. doi:10.1016/j.intimp.2012.08.01522982040
   PubMed Web of Science ®Google Scholar
• Zhang H-S, Zhang F-J, Li H, Liu Y, Du G-Y, Huang Y-H. Tanshinone IIA inhibits human esophageal cancer cell growth through miR-122-mediated PKM2 down-regulation. Arch Biochem Biophys. 2016;598:50–56. doi:10.1016/j.abb.2016.03.03127040384
   PubMed Web of Science ®Google Scholar
• Ren X, Wang C, Xie B, et al. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2017;796:233–241. doi:10.1016/j.ejphar.2016.11.04627894814
   PubMed Web of Science ®Google Scholar
• Hong L, Qing O, Ji Z, et al. Downregulation of miR-16 via URGCP pathway contributes to glioma growth. Sci Rep. 2017;7(1):13470. doi:10.1038/s41598-017-14035-229044221
   PubMedGoogle Scholar
• Wang Q, Li X, Zhu Y, Yang P. MicroRNA-16 suppresses epithelial-mesenchymal transition-related gene expression in human glioma. Mol Med Rep. 2014;10(6):3310–3314. doi:10.3892/mmr.2014.258325242314
   PubMed Web of Science ®Google Scholar
• Chaudhry MA, Sachdeva H, Omaruddin RA. Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. DNA Cell Biol. 2010;29(9):553–561. doi:10.1089/dna.2009.097820380575
   PubMed Web of Science ®Google Scholar
• Han J, Chen Q. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. Int J Clin Exp Pathol. 2015;8(10):12698–12707.26722459
   PubMed Web of Science ®Google Scholar
• Chen X, Li D, Gao Y, et al. Long intergenic noncoding RNA 00152 promotes glioma cell proliferation and invasion by interacting with MiR-16. Cell Physiol Biochem. 2018;46(3):1055–1064. doi:10.1159/00048883629669323
   PubMed Web of Science ®Google Scholar
• Singel SM, Cornelius C, Batten K, et al. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res. 2013;19(8):2061–2070. doi:10.1158/1078-0432.CCR-13-008223479679
   PubMed Web of Science ®Google Scholar
• Chen P, Lei L, Wang J, et al. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway. Cancer Sci. 2017;108(6):1157–1168. doi:10.1111/cas.1324728375585
   PubMed Web of Science ®Google Scholar
• Jin JK, Tien PC, Cheng CJ, et al. Talin1 phosphorylation activates beta1 integrins: a novel mechanism to promote prostate cancer bone metastasis. Oncogene. 2015;34(14):1811–1821. doi:10.1038/onc.2014.11624793790
   PubMed Web of Science ®Google Scholar
• Kang W, Kim SH, Cho HJ, et al. Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme. Oncotarget. 2015;6(29):27239–27251. doi:10.18632/oncotarget.483526336988
   PubMedGoogle Scholar
• Lu DY, Leung YM, Cheung CW, Chen YR, Wong KL. Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells. Biochem Pharmacol. 2010;80(8):1201–1209. doi:10.1016/j.bcp.2010.06.04620615395
   PubMed Web of Science ®Google Scholar
• Carbonell WS, DeLay M, Jahangiri A, Park CC, Aghi MK. beta1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Res. 2013;73(10):3145–3154. doi:10.1158/0008-5472.CAN-13-001123644530
   PubMed Web of Science ®Google Scholar